Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4240-5.

    New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway.

    Source

    Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA. cantley@helix.mgh.harvard.edu

    Abstract

    The most recently discovered PTEN tumor suppressor gene has been found to be defective in a large number of human cancers. In addition, germ-line mutations in PTEN result in the dominantly inherited disease Cowden syndrome, which is characterized by multiple hamartomas and a high proclivity for developing cancer. A series of publications over the past year now suggest a mechanism by which PTEN loss of function results in tumors. PTEN appears to negatively control the phosphoinositide 3-kinase signaling pathway for regulation of cell growth and survival by dephosphorylating the 3 position of phosphoinositides.

    PMID:
    10200246
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC33561
    Free PMC Article

    Images from this publication.See all images (2)Free text

    Figure 1
    Figure 2

    LinkOut - more resources

    Full Text Sources

    Other Literature Sources

    Medical

    Research Materials

      Supplemental Content

      Icon for HighWire Icon for PubMed Central

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk